Compounds > 2-(4'-methylpiperazino-1-methyl)-1,3-diazafluoranthene 1-oxide
Page last updated: 2024-08-25

2-(4'-methylpiperazino-1-methyl)-1,3-diazafluoranthene 1-oxide and Cancer of Liver

2-(4'-methylpiperazino-1-methyl)-1,3-diazafluoranthene 1-oxide has been researched along with Cancer of Liver in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gerin, Y; Hildebrand, J; Thys, O1

Other Studies

1 other study(ies) available for 2-(4'-methylpiperazino-1-methyl)-1,3-diazafluoranthene 1-oxide and Cancer of Liver

ArticleYear
Effects of the diazafluoranthen derivative AC-3579 (NSC-170561), a new experimental antitumour drug, on rat hepatoma.
    Pathologia Europaea, 1975, Volume: 10, Issue:4

    Topics: Aflatoxins; Animals; Antineoplastic Agents; Aza Compounds; Carcinoma, Hepatocellular; Endoplasmic Reticulum; Fluorenes; Liver; Liver Neoplasms; Male; Neoplasms, Experimental; Phosphates; Rats

1975